{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:26:52Z","timestamp":1763018812345,"version":"build-2065373602"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s13760-025-02822-y","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T11:31:26Z","timestamp":1749641486000},"page":"1429-1432","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Duloxetine-induced neuropsychiatric symptoms in a nonagenarian with chronic Pregabalin intake"],"prefix":"10.1007","volume":"125","author":[{"given":"Upinder","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Telagamsetti Sesha Sai","family":"Lahari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sankha Shubhra","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"issue":"4","key":"2822_CR1","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1345\/aph.1H423","volume":"41","author":"JR Horn","year":"2007","unstructured":"Horn JR, Hansten PD, Chan LN (2007) Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 41(4):674\u2013680","journal-title":"Ann Pharmacother"},{"issue":"3","key":"2822_CR2","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/24750573.2017.1419421","volume":"28","author":"KU Yazici","year":"2018","unstructured":"Yazici KU, Percinel Yazici I (2018) Visual hallucination induced by Duloxetine use: a male case diagnosed with generalized anxiety disorder. Psychiatry Clin Psychopharmacol 28(3):346\u2013348","journal-title":"Psychiatry Clin Psychopharmacol"},{"key":"2822_CR3","doi-asserted-by":"crossref","unstructured":"Rolma G, Jelcic N, Gnoato F, Cecchin D, Cagnin A (2013) Combined duloxetine and benzodiazepine-induced visual hallucinations in prodromal dementia with Lewy bodies. Gen Hosp Psychiatry 35(6):678.e7\u2013678.e9","DOI":"10.1016\/j.genhosppsych.2013.02.005"},{"issue":"5","key":"2822_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/WNF.0b013e3182a124cb","volume":"36","author":"T Tomita","year":"2013","unstructured":"Tomita T, Yasui-Furukori N, Kaneko S (2013) Visual hallucinations during Duloxetine treatment in a patient with major depressive disorder. Clin Neuropharmacol 36(5):170\u2013172","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"2822_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2210-11-2","volume":"11","author":"W Dimpfel","year":"2011","unstructured":"Dimpfel W, Hoffmann J (2011) Effects of rasagiline, its metabolite Aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro. BMC Pharmacol 11(1):2","journal-title":"BMC Pharmacol"},{"issue":"2","key":"2822_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1471-4159.2010.06625.x","volume":"113","author":"N Kumar","year":"2010","unstructured":"Kumar N, Laferriere A, Yu JSC, Leavitt A, Coderre TJ (2010) Evidence that Pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem 113(2):552\u2013561","journal-title":"J Neurochem"},{"issue":"1","key":"2822_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40360-020-0395-6","volume":"21","author":"G Mousailidis","year":"2020","unstructured":"Mousailidis G, Papanna B, Salmon A, Sein A, Al-Hillawi Q (2020) Pregabalin induced visual hallucinations\u2013 a rare adverse reaction. BMC Pharmacol Toxicol 21(1):16","journal-title":"BMC Pharmacol Toxicol"},{"key":"2822_CR8","unstructured":"Corum Pharmacy (2009) https:\/\/corumpharmacy.com\/wp-content\/uploads\/2020\/08\/Anticholinergic-cognitive-burden-scale.pdf."},{"issue":"4","key":"2822_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S2215-0366(14)70263-9","volume":"1","author":"SK Inouye","year":"2014","unstructured":"Inouye SK, Marcantonio ER, Metzger ED (2014) Doing damage in delirium: the hazards of antipsychotic treatment in elderly people. Lancet Psychiatry 1(4):312\u2013315","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"2822_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/pds.3903","volume":"25","author":"ECC Lai","year":"2016","unstructured":"Lai ECC, Hsieh CY, Wong MB, Lin SJ, Yang YK, Kao Yang YH et al (2016) Comparative risk of oral ulcerations among antipsychotics users - population-based retrospective cohort study. Pharmacoepidemiol Drug Saf 25(2):123\u2013132","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-025-02822-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-025-02822-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-025-02822-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T10:39:42Z","timestamp":1760351982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-025-02822-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2822"],"URL":"https:\/\/doi.org\/10.1007\/s13760-025-02822-y","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"type":"print","value":"0300-9009"},{"type":"electronic","value":"2240-2993"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardian (son).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}